We are live on
!
Find out more
NanoViricides
NNVC
NNVC
54 hedge funds and large institutions have $15.3M invested in NanoViricides in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
175% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 8
39% more call options, than puts
Call options by funds: $97K | Put options by funds: $70K
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
2% more funds holding
Funds holding: 53 → 54 (+1)
0% more ownership
Funds ownership: 0.48% → 0.48% (+0%)
8% less capital invested
Capital invested by funds: $16.7M → $15.3M (-$1.32M)
Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
22
Reduced
8
Closed
6
Calls
$97K
Puts
$70K
Net Calls
+$27K
Net Calls Change
-$402K
Top Buyers
Top Sellers
| 1 |
CG
Colony Group
Boston,
Massachusetts
|
-$1.3M |
| 2 |
Goldman Sachs
New York
|
-$141K |
| 3 |
WAM
Weatherly Asset Management
Del Mar,
California
|
-$128K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$111K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$67.5K |
